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Background:  With advances in medical and PCI related therapies, the superiority of CABG over PCI as the revascularization strategy of choice in 
diabetics with multivessel disease (MVD) is being questioned. We performed a systematic review to compare the safety and efficacy of PCI to CABG 
in diabetic patients with MVD.
Methods:  All comparative studies published on PCI with drug eluting stents (DES) vs. CABG for MVD in diabetic patients until 2010 were identified 
using an electronic search and reviewed using a random effects model. Endpoints evaluated were all cause mortality, MI, stroke, TVR and MACE, 
which was defined as a composite of the other end points.
Results:  12 studies comprising 9520 patients were included in the analysis. 4598 patients underwent PCI with DES. There was no significant 
difference between the two groups in the incidence of all cause mortality (OR:0.87, 95% CI:0.74-1.02, p=0.08) or MI (OR:1.37, 0.93-2.01, p=0.11). 
Whereas TVR occurred significantly more frequently in patients undergoing PCI (OR:4.2, 3.0-5.88, p<0.001), stroke occurred significantly less 
(OR:0.43, 0.25-0.74,p=0.002). Overall, MACE rates were higher in patients undergoing PCI (OR:1.86,1.47-2.4, p<0.001).
Conclusions:  We conclude that in diabetics undergoing revascularization for MVD, PCI with DES is comparable to CABG in terms of mortality. 
CABG leads to reduced repeat revascularization but increased stroke. A tailored approach to each patient’s anatomy and stroke risk may lead to the 
optimal management strategy. 
